EMCORE Corporation Announces New Tunable TOSA 10 Gb/s Optical Component Platform

EMCORE Corporation (NASDAQ: EMKR), a leading provider of compound semiconductor-based components and subsystems for the fiber optic and solar power markets, today announced its plans to release a new full-band tunable TOSA (transmit optical sub-assembly) product line.

The Tunable TOSA product line combines EMCORE's field proven tunable External Cavity Laser technology with a co-packaged Mach-Zehnder modulator, empowering the next generation of ultra-high-density 10 Gb/s tunable interfaces. The Tunable TOSA provides excellent optical performance while tuning across more than 90 channels on the 50GHz ITU grid. With its low power consumption, the EMCORE Tunable TOSA is compatible with existing XFP module and line-card requirements. The Tunable TOSA also boasts optical performance similar to existing solutions using discrete tunable laser and external lithium-niobate modulator. EMCORE believes this will allow for the migration of existing 300-pin MSA modules to new smaller and pluggable form-factors.

Stephen Krasulick, Vice President and General Manager of EMCORE's Fiber Optics Division, stated, "Increased density and flexibility are key requirements all the way up the value-chain, translating to reductions in both capital and operation expenditures at the carrier level. The EMCORE Tunable TOSA will be the optical engine that delivers these benefits into the 10 Gb/s DWDM market."

EMCORE is conducting private demonstrations of its new Tunable TOSA technology at the Optical Fiber Communication Conference and Exposition (OFC) in San Diego on March 24-26. EMCORE plans to begin early sampling to lead customers within the first half of 2009.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.